Page 282 - Health Medical Pharma
Selena Gomez opts for mental health treatment to cure emotional breakdown
American singer Selena Gomez recently entered a mental health facility for receiving treatment for an emotional breakdown. She was hospitalized twice in the last two weeks.The 26-year-old singer is trying to take control of her ongoing issues related to anxiety and depression, reported E! Online."Selena has been trying really hard recently to remain focused, and not let her health affect her. She has been actively writing new music, and moved to Orange County for a change of place and a fresh breath of air. Ultimately, with all of her arising health issues, Selena started to feel super overwhelmed," explained an insider.Multiple sources told TMZ that the singer was at her Studio City, CA home, in the last week of September, when the first emergency hit. She was dejected and emotional over an alarmingly low white blood cell count in the wake of her kidney transplant. According to TMZ, a family member drove her to Cedars-Sinai Medical Center in L.A.Selena was released a few days later ..
Colour-changing contact lens can monitor eye treatments
Scientists have developed colour-changing contact lenses that can deliver drugs and monitor eye treatments. Researchers from China Pharmaceutical University and Southeast University in China sought to create a drug-delivering contact lens that would change colour as the medication is released into the eye. According to the study published in the journal ACS Applied Materials & Interfaces, the lens could control and indicate the sustained release of many ophthalmic drugs. It is difficult to known how much medication is actually getting to the eye, when eye drops and ointments are administered. This is because the eyes tend to reject foreign elements, and tears start rapidly start flowing when something goes into the eye. While this process is usually helpful for avoiding infection and damage from foreign objects, it can hinder the uptake of much-needed medications. Contact lenses may be a more effective way to deliver drugs directly to the eye, but real-time monitoring of drug ...
'Novel DNA vaccine against Ebola safe, effective'
Scientists, including one of Indian-origin, have developed a novel synthetic DNA vaccine against Ebola which they say is safe and offers a long-term protection from the virus. Using a unique approach, researchers at The Wistar Institute in the US, designed optimised synthetic DNA vaccine candidates targeting a virus surface protein called glycoprotein. They demonstrated efficacy of the novel vaccine candidates and durability of the immune responses in animal models. Results, published in the Journal of Infectious Diseases, showed strong immune responses one year after the last dose, supporting the long-term immunogenicity of the vaccine -- a particularly challenging area for Ebola vaccines. "The success of intradermal delivery of a low-dose regimen is very encouraging. The ultimate goal of our work is to create effective and safe vaccines that are optimised for field use in at-risk areas," said Ami Patel from The Wistar Institute. The researchers optimised a shorter, dose-sparing, ...
Foreign countries extort lower prices from US drug-makers for their citizens: Trump
US President Donald Trump has alleged that foreign countries extort lower prices from US drug-makers for their citizens, as he signed two pieces of legislation into law that aim to inform consumers about drug prices. Both measures, the Know the Lowest Price Act and the Patient Right to Know Drug Prices Act, aim to end the drug industry's so-called gag orders of pharmacists, which prevent them from discussing cheaper price options with consumers. These price options include discussing whether a medication may be less expensive if using insurance or paying out-of-pocket. "I have directed my administration to confront the global freeloading of US taxpayers. Foreign countries extort lower prices from US drug-makers for their citizens, subsidized by higher cost prices for American citizens, Trump said at the White House, without mentioning the names of the nations. "All research and development and everything is borne by our country, and other countries are not asked to, you know, pick up .
Novel DNA vaccine against Ebola virus safe, effective
Scientists, including one of Indian-origin, have found that the novel synthetic DNA vaccine is safe against Ebola virus and offers a long-term alternative to traditional vaccines.
Indian drug-maker to produce, market oral syrup in USA
: Aurobindo Pharma Limited Thursday said it would be making and marketing azithromycin oral suspension in the US market after getting final approval from the US Food and Drug Administration (USFDA). The oral suspension is to treat mild-to-moderate infections, a press release said here. The oral suspension would come in 100 mg /5 ml and 200 mg/5 ml and is a generic version of zithromax oral suspension of Pfizer Inc, the release said. The product had an estimated market size of USD 71 million for the 12 months ending August 2018, it said quoting market reports. Aurobindo now has a total of 386 ANDA (abbreviated new drug application) approvals (357 final approvals including 19 from Aurolife Pharma LLC and 29 tentative approvals) from USFDA, the release added.
Obesity in your 20s linked to reduced life expectancy: Study
If you are obese or overweight in your 20s and 30s, expect to lose up to 10 years in life expectancy, researchers have warned.
Aurobindo Pharma gets USFDA nod for infections treatment drug
Drug firm Aurobindo Pharma Thursday said it has received final nod from the US health regulator for its Azithromycin oral suspension used for treatment of infections. The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Azithromycin oral suspension 100 mg /5 mL and 200 mg/5 mL, Aurobindo Pharma said in a statement. The product is a generic version of Pfizer Inc's Zithromax oral suspension, it added. "The product will be launched in November 2018," Aurobindo Pharma said. Azithromycin oral suspension is indicated for the treatment of patients with mild to moderate infections, it added. According to IQVIA, the approved product has an estimated market size of USD 71 million for the 12 months ending August 2018, Aurobindo Pharma said. The company now has a total of 386 abbreviated new drug application (ANDA) approvals (357 final approvals including 19 from Aurolife Pharma LLC and 29 tentative approvals) from the USFDA, it ...
3-in-1 vaccine against traveller's diarrhoea created
Researchers say they have designed the first-ever vaccine to deliver a one-two-three punch against the main causes of traveller's diarrhoea. The approach could help save lives in developing countries, where it's estimated that three common pathogens kill over 100,000 children under the age of five each year, according to the research published in the journal Vaccine. The vaccine designed by Mario Monteiro from the University of Guelph in Canada combines proteins from pathogenic E coli with sugars from Shigella and Campylobacter jejuni. All three bugs are major causes of bacterial diarrhoea globally. In tests with mice, the vaccine provided immunity against all three pathogens, researchers said. No licensed vaccines exist against any of these pathogens, they said. A sugar-based vaccine developed by Monteiro earlier against campylobacter alone is currently undergoing human trials but is still an estimated decade away from potential release. He said this new three-in-one approach may ...
New 3-in-1 vaccine against traveller's diarrhoea
In a first, researchers have developed a vaccine for the three main pathogens that cause traveller's diarrhoea and deaths of children in developing countries, where it is estimated that these three common pathogens kill more than one lakh children under age five each year.
Chewing gum can help deliver vitamins
Chewing gum can be effective at delivering some vitamins to the body, according to scientists who suggest that the habit could be a strategy to help reduce the epidemic of vitamin deficiency around the world. For the first time, researchers closely scrutinised vitamin delivery from chewing gum. "I was slightly surprised that no one had done a study like this before given the number of supplement-containing gum products on the market," said Joshua Lambert, a professor at Pennsylvania State University in the US. "But there is no requirement that nutritional gums be tested for efficacy, since they fall into the category of dietary supplements," said Lambert. To find out if supplemented gum contributes vitamins to chewers' bodies, researchers had 15 people chew two off-the-shelf supplemented gums and measured the levels of eight vitamins released into their saliva. In a separate experiment on the same subjects, the researchers measured the levels of seven vitamins in their plasma. The ...
Concept Medical Inc. raises Rs. 440Cr for first sirolimus-coated balloon
Concept Medical Inc. has approached the FDA for an Investigational Device Exemption (IDE) for their Sirolimus-Coated Balloon (DCB).To support this process, they have raised Rs. 440 crores (for an undisclosed valuation) from cardiologist and serial entrepreneur Dr. Kiran Patel (Tampa, Florida). An IDE allows the investigational device to be used in a clinical study to collect safety and effectiveness data.The funds will also be utilized to augment clinical data and clinical registries to qualify for re-imbursement in the European markets, where the company has commercially launched the product.CMI, headquartered in Florida, has a manufacturing subsidiary in India, by the name, Envision Scientific Pvt. Ltd. (ESPL), where all their products are made. A portion of the funds will also be utilized to bolster the manufacturing operations to meet the increasing demand for their products globally. Their global distribution and marketing network are operated from offices in India, Singapore, ...
This amino acid may help with type 2 diabetes
According to a new research, the amino acid called alanine may provide a brief lowering of glucose levels by altering energy metabolism in cells.Type 2 diabetes is driven by many metabolic pathways, with some pathways driven by amino acids, the molecular building blocks for proteins."Our study shows that it's possible we can use specific nutrients, in this case, amino acids, to change metabolism in a cell, and these changes in metabolism can change how cells take up and release glucose in a beneficial way," said study author Mary-Elizabeth Patti. The study was recently published in the Journal of Molecular Metabolism.Performed in cells and in mice, her group's research began with an attempt to see what nutrients might activate a key protein called AMP kinase (AMPK)."AMPK is an enzyme in cells throughout the body that is activated when nutrient supplies are low, or in response to exercise. AMPK then causes a lot of beneficial changes in the cell, turning on genes that serve to increase
Aurobindo Pharma off day's low after USFDA nod
Aurobindo Pharma was down 0.6% to Rs 773.60 at 12:35 IST on BSE, with the stock coming off day's low after the company announced securing USFDA approval for Azithromycin Oral Suspension.
Mamata asks media to spread awareness on obesity
West Bengal Chief Minister Mamata Banerjee Thursday said that media should play a crucial role in spreading awareness on obesity. On the occasion of World Obesity Day, she also urged others to help in raising the awareness level of the people about the "prevalence, severity and diversity of the stigma about weight." On #WorldObesityDay2018 let us raise awareness about the prevalence, severity and diversity of the stigma about weight. The media must play a crucial role in this regard, Banerjee wrote on her Twitter handle today. The World Obesity Federation, this year, has called upon the people to end the stigma associated with obesity besides urging the media to stop using stigmatising language and imagery against obese people. Instead it should portray obesity in a fair, accurate and informative manner.
Cataract management has evolved to refractive surgery (October 11 is World Sight Day)
Cataract is caused due to the opacification of the natural lens in the eye, leading to cloudy vision. It is a common occurrence in the elderly -- and a commonly performed surgery across the world. The management of cataract has evolved recently from a stage of visual restoration to a stage of refractive surgery. Several new technologies have come up over the recent past to achieve this outcome.
Mr. Kieran Murphy (President and CEO, GE Healthcare) at GE HCI Alumni Day
/ -- Mr. Kieran Murphy (President & CEO, GE Healthcare) lauded the alumni, their parents and the GE Healthcare Institute Skill Creation team for their efforts in helping India's healthcare sector at the GE Healthcare Institute's Alumni Day held on the 9th of October, 2018. (Photo: https://mma.prnewswire.com/media/767498/Kieran_Murphy_GE_Healthcare.jpg ) (Photo: https://mma.prnewswire.com/media/767499/GE_HCI_Alumni_Day.jpg ) (Photo: https://mma.prnewswire.com/media/767500/GE_HCI_Saint_Elizabeth_Health_Care.jpg ) India has 84% shortfall in the healthcare technician demand-supply gap (as projected by National Skill Development Corporation [NSDC]). This is why GE Healthcare partnered with the Tata Trusts in 2016 and launched a unique skill creation initiative to train 10,000 youth in various technical areas of expertise in healthcare over a period of 3 years. At the Alumni Day (Mumbai), the alumni came back to share their stories, be awarded for their achievements and most importantly
McGraw-Hill Education Launches Landmark 20th Edition of Harrison's Principles of Internal Medicine
/ -- McGraw-Hill Education today announced the launch of the 20th edition of Harrison's Principles of Internal Medicine in Asia and Africa. First published in 1950, Harrison's is considered to be the foremost, leading medical reference book worldwide for medical and healthcare students, trainees, their teachers and medical practitioners. Each new edition is comprehensively updated to reflect the latest thinking and information in medical science, diagnoses and treatments. The landmark 20th edition has been extensively updated with more than 25% new and revised content, covering areas such as: the latest diagnostic methods and technologies; LGBT healthcare; problems associated with microbial resistance to therapeutics; clinical applications of epigenetics and genomics; emerging hi-tech treatments for neurological disease; and disease pathogenesis. A team of over 700 contributors and six world-renowned editors created the new, definitive 20th edition, which presents essential medical ...
Markers of dairy fat consumption lower risk of type 2 diabetes
Turns out, higher levels of biomarkers of dairy fat consumption are associated with a lower risk of developing type 2 diabetes, a new study has revealed.The study, published in PLOS Medicine, was undertaken by an international consortium led by scientists at the Medical Research Council Epidemiology Unit, University of Cambridge, and the Friedman School of Nutrition Science and Policy at Tufts University.International nutritional guidelines commonly recommend regular consumption of dairy products as an important source of key nutrients, and in high-income countries, eating low-fat dairy products is encouraged as part of overall recommendations to limit saturated fat consumption. In some researches, consumption of dairy products, in particular, yogurt and cheese, has been associated with a lower incidence of type 2 diabetes.Biomarkers are tell-tale molecules in the body that can be measured accurately and consistently, and act as indicators of dietary consumption.Concentrations in body
Babies of overweight mothers may develop self-regulation problems
According to a recent study, a mother's weight during early pregnancy may affect how well her baby is able to self-regulate during its first months and years of life.The research suggested that there is a one in five chance that overweight or obese women will have babies who suffer from multiple regulatory problems, and these babies may also show a delay in some developmental milestones when they reach childhood.Previous research has found that one in every five infants struggles to self-regulate in the first year of life. This means that these babies may cry excessively, have problems feeding or difficulties falling asleep unless soothed by a caregiver. As they grow older, such children often show behavioural and neurodevelopmental problems such as hyperactivity or difficulties concentrating, as well as having poorer muscle function. Some have lower IQs or are placed on the autism spectrum.As part of the study, researchers drew on data from 3,117 women from different Finnish towns ...